Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study for Immunogenicity and Safety of ASP7374 for Subcutaneous and Intramuscular Vaccination in Healthy Adults

NCT01393951 is registered in ClinicalTrials.gov with UMN Pharma Inc. as lead sponsor.

NCT NCT01393951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01393951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study for Immunogenicity and Safety of ASP7374 for Subcutaneous and Intramuscular Vaccination in Healthy Adults
Lead sponsor
UMN Pharma Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2011
Completion date
December 31, 2011
Enrollment
165 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, immunogenicity of asp7374